Exposure of PHGDH-kd ER+ breast cancer cells to cytotoxic chemotherapy (carboplatin or doxorubicin) leads to increased mitochondrial ROS and blocks the enrichment of CSCs induced by chemotherapy [166,167]. Here, PHGDH is linked to breast carcinoma.